MiR-525-5p Repressed Metastasis and Anoikis Resistance in Cervical Cancer via Blocking UBE2C/ZEB1/2 Signal Axis
Author:
Funder
the Science and Technology Project of Xianyang
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Link
http://link.springer.com/content/pdf/10.1007/s10620-019-05916-9.pdf
Reference30 articles.
1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J. Jemal A (2015) Global cancer statistics. CA Cancer J Clin. 2012;65:87–108. https://doi.org/10.3322/caac.21262 .
2. Qureshi R, Arora H, Rizvi MA. EMT in cervical cancer: its role in tumour progression and response to therapy. Cancer Lett. 2015;356:321–331. https://doi.org/10.1016/j.canlet.2014.09.021 .
3. Yadav SS, Prasad CB, Prasad SB, et al. Anti-tumor activity of staurosporine in the tumor microenvironment of cervical cancer: an in vitro study. Life Sci. 2015;133:21–28. https://doi.org/10.1016/j.lfs.2015.04.019 .
4. Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochem Biophys Acta. 2013;1833:3481–3498. https://doi.org/10.1016/j.bbamcr.2013.06.026 .
5. Yang J, Zheng Z, Yan X, Li X, Liu Z, Ma Z. Integration of autophagy and anoikis resistance in solid tumors. Anat Rec. 2013;296:1501–1508. https://doi.org/10.1002/ar.22769 .
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Empagliflozin drives ferroptosis in anoikis-resistant cells by activating miR-128-3p dependent pathway and inhibiting CD98hc in breast cancer;Free Radical Biology and Medicine;2024-08
2. Targeting anoikis resistance as a strategy for cancer therapy;Drug Resistance Updates;2024-07
3. microRNAs: critical targets for treating rheumatoid arthritis angiogenesis;Journal of Drug Targeting;2023-11-23
4. MiR-525-5p inhibits diffuse large B cell lymphoma progression via the Myd88/NF-κB signaling pathway;PeerJ;2023-11-06
5. Unleashing the pathological imprinting of cancer in autoimmunity: Is ZEB1 the answer?;Life Sciences;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3